Keywords: biovitrum, initiates, ph, ii, trial, neuropathic, painkiller

Biovitrum initiates Ph II trial of neuropathic painkiller

Article | 14 May 2007

Print This

Swedish biopharmaceutical company Biovitrum has initiated a Phase II clinical trial of a novel drug candidate in neuropathic pain, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in